There are 2867 resources available
Welcome to the Conversation
Presenter: Lesley Fallowfield
Session: BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers
Resources:
Slides
Webcast
Welcome and introduction
Presenter: Laura-Maria Krabbe
Session: Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer
Resources:
Webcast
Welcome, Faculty Introductions, and Overview of Agenda
Presenter: Karim Fizazi
Session: PeerVoice - Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
Resources:
Webcast
Welcome and Introductions
Presenter: Martin Reck
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
How Would You Assess Risk of Recurrence in This Patient With HR+/HER2- EBC? Patient video will be included
Presenter: Wolfgang Janni
Session: Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central
Resources:
Webcast
What Now Doc? A Patient’s Perspective
Presenter: Tihana Gašpert
Session: BeiGene Switzerland GmbH - Standard of Care is Not Enough! Talking Immunotherapy Clinical Trials in GI Cancers
Resources:
Slides
Webcast
State-of-the-Art Interventions in mHSPC: New Evidence, New Expectations
Presenter: Bertrand Tombal
Session: PeerVoice - Contemporary Management of Prostate Cancer: Updated Approaches for Improved Outcomes in nmCRPC and mHSPC
Resources:
Webcast
Development of an MDM2-p53 Antagonist for STS and Other Indications
Presenter: Patrick Schoeffski
Session: Boehringer Ingelheim International GmbH - Breaking Through the Firewall: New Therapeutic Strategies to Disrupt Cancer’s Operating Systems
Resources:
Webcast
Question 1: How should we manage oligometastatic disease?
Presenter: Joe O'Sullivan
Session: Janssen-Cilag International NV - Exploring questions in metastatic prostate cancer
Resources:
Webcast
Treatment Considerations for Patients With High-Risk HR+/HER2- EBC: What do the Latest Data Show?
Presenter: Miguel Martin Jimenez
Session: Medscape Oncology Global - Improving Outcomes in Patients With High-Risk HR+/HER2- EBC: Keeping the Patient Central
Resources:
Webcast